Connect your AI

Nuvation Bio NUVB Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

ImmunomeIMNM

$2.83M-32.1%

ArriVent BioPharma, Inc.AVBP

$370K+208%

Syndax PharmaceuticalsSNDX

$1.21M-32.7%

IDEAYA Biosciences, Inc.IDYA

$22.61M-7.4%

ImmunityBio, Inc.IBRX

11.1%+0.1pp

Tango TherapeuticsTNGX

$34.65M-12.7%

Other financials

Income statement

Revenue$83.2M+2,599%

Gross profit$9.8M+1,340%

Operating income$3.9M+107%

Net income$5.4M+110%

EPS (diluted)$0.01+106%

Balance sheet

Cash & equivalents$125.4M+161%

Total debt$57.2M+401%

Total equity$319.6M-23.8%

Total assets$610.2M+23.9%

Cash flow

Operating cash flow$5.1M+112%

CapEx$48.0K-33.3%

Free cash flow$5.0M+112%

Valuation

Market cap$2.1B+150%

Enterprise value$2.03B+154%

P/S14.7×-62.0×

Profitability

Gross margin54.3%+39.5pp

Operating margin-105%-52.0pp

Net margin-102.1%-50.6pp

FCF margin-93.5%-45.2pp

Returns & leverage

Return on equity-39.5%-15.8pp

Debt / equity0.2×+0.2×

Current ratio7.4×-1.6×

Where this comes from

Reported directly by Nuvation Bio in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Nuvation Bio’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvation Bio's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Nuvation Bio's operating lease ROU assets?: Nuvation Bio (NUVB) reported operating lease ROU assets of $3.6M in Q1 2026.
How has Nuvation Bio's operating lease ROU assets changed year-over-year?: Nuvation Bio's operating lease ROU assets decreased by 32.5% year-over-year, from $5.33M to $3.6M.
What is the long-term trend for Nuvation Bio's operating lease ROU assets?: Over 4 years (2021 to 2025), Nuvation Bio's operating lease ROU assets has grown at a 8.1% compound annual growth rate (CAGR), from $2.87M to $3.92M.
What does operating lease ROU assets mean?: Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.